Advances in the Identification of Novel Urinary Biomarkers for Diabetic Kidney Disease
Journal of Diabetes Research · 2026-01 · 2026 (1)
DOI: 10.1155/jdr/7990072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Diabetes Research, online erschienen am 23.07.2026. Verfasst von Yujie Jin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Genetic Metabolism, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical U…. Hauptthemen laut MEDLINE: Biomarkers, Diabetic Nephropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical Foundation, Anhui Provincial Higher Education Institutions Innovation Team Project, Yijishan Hospital.
Abstract (Originalsprache)
Diabetic kidney disease (DKD) is a major microvascular complication of diabetes and remains one of the leading causes of end‐stage renal disease, significantly affecting patients′ survival rates and quality of life. Currently, commonly used clinical assessment indicators include proteinuria and estimated glomerular filtration rate (eGFR); however, these indicators have limited sensitivity, making it difficult to detect early kidney damage in a timely manner and to accurately monitor disease progression. This review provides a comprehensive overview of recent progress in identifying various urinary biomarkers that reflect renal tubular injury, oxidative stress, inflammatory responses, fibrotic remodeling, metabolic dysregulation, and exosomal components. Furthermore, we discuss the potential clinical applications of these biomarkers in DKD early diagnosis, disease stratification, and prognostic evaluation. Looking ahead to the future and the ongoing development of multiomics integration and artificial intelligence–assisted modeling, urinary biomarkers are expected to drive DKD diagnosis and management toward a future characterized by early detection, precision, dynamic monitoring, and noninvasive assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Genetic Metabolism, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuhu, Anhui, China.
- Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuhu, Anhui, China.
- Anhui Province Key Laboratory of Basic Research and Transformation of Age-Related Diseases, Wannan Medical University, Wuhu, Anhui, China.
- Department of Biochemistry and Molecular Biology, Wannan Medical University, Wuhu, Anhui, China.
ORCID-Profile: Jialin Gao
Förderung
- China Medical Foundation
- Anhui Provincial Higher Education Institutions Innovation Team Project
- Yijishan Hospital
- Clinical Medical Research Transformation Project of Anhui Province
- National Natural Science Foundation of China
- Major Program of Anhui Provincial Health and Medical Research Project
Zitieren
APA
Jin, Y., Ma, Y., Yao, Y., Wang, M., Ni, C., Shang, S., Cui, Y., Wang, X., Ling, Y., Sun, Y., Pei, Q., Liu, S., Wang, L., & Gao, J. (2026). Advances in the Identification of Novel Urinary Biomarkers for Diabetic Kidney Disease. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/7990072
Vancouver
Jin Y, Ma Y, Yao Y, Wang M, Ni C, Shang S, et al. Advances in the Identification of Novel Urinary Biomarkers for Diabetic Kidney Disease. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/7990072
BibTeX
@article{Jin2026,
author = {Jin, Yujie and Ma, Yan and Yao, Yan and Wang, Mengru and Ni, Chunchen and Shang, Shujuan and Cui, Yongxin and Wang, Xinyu and Ling, Ye and Sun, Yumeng and Pei, Qirui and Liu, Shiqiang and Wang, Lizhuo and Gao, Jialin},
title = {Advances in the Identification of Novel Urinary Biomarkers for Diabetic Kidney Disease},
journal = {Journal of Diabetes Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jdr/7990072}
}
EUVIMED